Chemoinformaics analysis of Methyl ganoderenate D
Molecular Weight | 540.697 | nRot | 6 |
Heavy Atom Molecular Weight | 496.345 | nRig | 27 |
Exact Molecular Weight | 540.309 | nRing | 4 |
Solubility: LogS | -4.554 | nHRing | 0 |
Solubility: LogP | 3.385 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 32 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
nHA | 7 | APOL | 88.3929 |
nHD | 1 | BPOL | 50.2171 |
QED | 0.349 |
Synth | 5.136 |
Natural Product Likeliness | 2.497 |
NR-PPAR-gamma | 0.299 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.996 |
Pgp-sub | 0 |
HIA | 0.024 |
CACO-2 | -5.152 |
MDCK | 0.0000188 |
BBB | 0.957 |
PPB | 0.79863 |
VDSS | 0.467 |
FU | 0.129161 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.738 |
CYP2c19-inh | 0.398 |
CYP2c19-sub | 0.959 |
CYP2c9-inh | 0.479 |
CYP2c9-sub | 0.389 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.214 |
CYP3a4-inh | 0.86 |
CYP3a4-sub | 0.781 |
CL | 15.321 |
T12 | 0.37 |
hERG | 0.001 |
Ames | 0.022 |
ROA | 0.734 |
SkinSen | 0.024 |
Carcinogencity | 0.245 |
EI | 0.078 |
Respiratory | 0.609 |
NR-Aromatase | 0.658 |
Antiviral | Yes |
Prediction | 0.835914 |